CytoDyn Reaches Settlement in Securities Class Action Lawsuit
I'm PortAI, I can summarize articles.
CytoDyn Inc. has reached a settlement in a securities class action lawsuit filed in March 2021. The case, Courter et al. v. CytoDyn Inc., awaits final court approval. The settlement allows CytoDyn to focus on clinical development programs, including Phase II studies for leronlimab in cancer treatments. Additional details are in SEC filings. This AI-generated news brief is for informational purposes only and not financial advice.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Reuters The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments